Search Results - John Higgins

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Oral vaccination with a rough attenuated mutant of S. Infantis increases post-wean weight gain and prevents clinical signs of salmonellosis in S. Typhimurium challenged pigs

    Oral vaccination with a rough attenuated mutant of S. Infantis increases post-wean weight gain and prevents clinical signs of salmonellosis in S. Typhimurium challenged pigs by Foster, Neil, Richards, Luke, Higgins, John, Kanellos, Theo, Barrow, Paul

    Published 2016
    Get full text
  2. 2
    IL-36α induces maturation of Th1-inducing human MDDC and synergises with IFN-γ to induce high surface expression of CD14 and CD11c

    IL-36α induces maturation of Th1-inducing human MDDC and synergises with IFN-γ to induce high surface expression of CD14 and CD11c by Higgins, John, Mutamba, Shilla, Mahida, Yashwant R., Barrow, Paul, Foster, Neil

    Published 2015
    Get full text
  3. 3
    IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation

    IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation by Penha, Rafael, Higgins, John, Mutamba, Shilla, Barrow, Paul, Mahida, Yashwant R., Foster, Neil

    Published 2016
    Get full text
  4. 4
    Proactive dairy cattle disease control in the UK: veterinary surgeons' involvement and associated characteristics

    Proactive dairy cattle disease control in the UK: veterinary surgeons' involvement and associated characteristics by Higgins, Helen M., Huxley, Jonathan, Wapenaar, Wendela, Green, Martin J.

    Published 2013
    Get full text
  5. 5
    The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia

    The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia by Litton, E., Baker, S., Erber, W., French, C., Ferrier, J., Hawkins, D., Higgins, A., Hofmann, Axel, De Keulenaer, B., Farmer, Shannon, McMorrow, J., Olynyk, John, Richards, T., Towler, Simon, Webb, S.

    Published 2014
    Get full text
  6. 6
    Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness

    Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness by The, I., Litton, E., Baker, S., Erber, W., Farmer, Shannon, Ferrier, J., French, C., Gummer, J., Hawkins, D., Higgins, A., Hofmann, Axel, De Keulenaer, B., McMorrow, J., Olynyk, John, Richards, T., Towler, S., Trengove, R., Webb, S., The, A.

    Published 2016
    Get full text
  7. 7
    Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: A nested cohort study

    Hepcidin predicts response to IV iron therapy in patients admitted to the intensive care unit: A nested cohort study by Litton, E., Baker, S., Erber, W., Farmer, Shannon, Ferrier, J., French, C., Gummer, J., Hawkins, D., Higgins, A., Hofmann, A., De Keulenaer, B., McMorrow, J., Olynyk, John, Richards, T., Towler, S., Trengove, R., Webb, S., Chapman, A., Jenkinson, E., Palermo, A., Roberts, B.

    Published 2018
    Get full text

Search Tools: